“The reason I created the alliance management function about four or five years ago was a recognition that our company primarily developed organically, inventing most of our products in-house. It means we are very much geared for organic growth, which offers many benefits. But it also means that we do not have so much experience in collaborating with others. So I am very pleased that we are now being recognized for focusing on it.”
Lars Fruergaard Jørgensen is Senior VP for Corporate Development and IT at Novo Nordisk, and the recognition he is talking about is a survey from the Boston Consulting Group, placing Novo at the top of the list of preferred global collaboration partners for the biotech industry.